- Home
- RCUS vs CRAI Comparison
RCUS vs CRAI Comparison
Compare RCUS & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- CRAI
- Stock Information
- Founded
- RCUS 2015
- CRAI 1965
- Country
- RCUS United States
- CRAI United States
- Employees
- RCUS N/A
- CRAI N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- CRAI Other Consumer Services
- Sector
- RCUS Health Care
- CRAI Consumer Discretionary
- Exchange
- RCUS Nasdaq
- CRAI Nasdaq
- Market Cap
- RCUS 1.4B
- CRAI 1.2B
- IPO Year
- RCUS 2018
- CRAI 1998
- Fundamental
- Price
- RCUS $14.71
- CRAI $193.84
- Analyst Decision
- RCUS Buy
- CRAI Buy
- Analyst Count
- RCUS 12
- CRAI 1
- Target Price
- RCUS $34.50
- CRAI $212.00
- AVG Volume (30 Days)
- RCUS 767.1K
- CRAI 34.6K
- Earning Date
- RCUS 11-06-2024
- CRAI 10-31-2024
- Dividend Yield
- RCUS N/A
- CRAI 1.01%
- EPS Growth
- RCUS N/A
- CRAI 24.54
- EPS
- RCUS N/A
- CRAI 6.18
- Revenue
- RCUS $263,000,000.00
- CRAI $672,592,000.00
- Revenue This Year
- RCUS $112.97
- CRAI $10.95
- Revenue Next Year
- RCUS N/A
- CRAI $2.76
- P/E Ratio
- RCUS N/A
- CRAI $31.34
- Revenue Growth
- RCUS 119.17
- CRAI 10.74
- 52 Week Low
- RCUS $13.50
- CRAI $92.07
- 52 Week High
- RCUS $20.31
- CRAI $208.38
- Technical
- Relative Strength Index (RSI)
- RCUS 40.35
- CRAI 53.47
- Support Level
- RCUS $14.15
- CRAI $188.57
- Resistance Level
- RCUS $15.01
- CRAI $207.76
- Average True Range (ATR)
- RCUS 1.00
- CRAI 5.93
- MACD
- RCUS -0.20
- CRAI -1.16
- Stochastic Oscillator
- RCUS 11.49
- CRAI 39.87
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About CRAI CRA International Inc.
CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States.